Article
Cerebrolysin, Hemorrhagic Transformation, and Anticoagulation Timing after Reperfusion Therapy in Stroke: Secondary Analysis of the CEREHETIS Trial
2024-10-18
Abstract excerpt
<title>Abstract</title> <p> Background Evidence supports Cerebrolysin’s efficacy in reducing hemorrhagic transformation (HT), but its impact on the timing of resuming anticoagulation therapy in stroke patients remains unclear. Methods A <italic>post hoc</italic> survival analysis of the CEREHETIS trial (ISRCTN87656744) was conducted. Patients with middle cerebral artery infarction ( <italic>n</italic> = 2...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1a023e7c-0dfc-582a-ab29-84a349fdf8e3
- DOI
- 10.21203/rs.3.rs-5101232/v1
